Cargando…

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort

BACKGROUND: COVID-19 associated coagulopathy (CAC) is associated with an increase in thromboembolic events. Current guidelines recommend prophylactic heparins in the management of CAC. However, the efficacy of this strategy in the intensive care population remains uncertain. OBJECTIVE: We aimed to m...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Berg, Tom W., Mulder, Mark M. G., Alnima, Teba, Nagy, Magdolna, van Oerle, Rene, Beckers, Erik A. M., Hackeng, Tilman M., Hulshof, Anne-Marije, Sels, Jan-Willem E. M., Henskens, Yvonne M. C., van der Horst, Iwan C. C., ten Cate, Hugo, Spronk, Henri M. H., van Bussel, Bas C. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582511/ https://www.ncbi.nlm.nih.gov/pubmed/36277784 http://dx.doi.org/10.3389/fcvm.2022.929284

Ejemplares similares

Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study
por: Nagy, Magdolna, et al.
Publicado: (2022)

Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021)

Applications of rotational thromboelastometry in heparin monitoring in critical COVID-19 disease: Observations in the Maastricht Intensive Care COVID cohort
por: Schultinge, Lejan, et al.
Publicado: (2023)

Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort—Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

COVID-19 Coagulopathy: From Pathogenesis to Treatment
por: Alnima, Teba, et al.
Publicado: (2022)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort
por: Mulder, Mark M. G., et al.
Publicado: (2021)

Hemostasis and fibrinolysis in COVID‐19 survivors 6 months after intensive care unit discharge
por: Hulshof, Anne‐Marije, et al.
Publicado: (2021)

Sensitive Measurement of Clinically Relevant Factor VIII Levels in Thrombin Generation Assays Requires Presence of Factor XIa
por: van de Berg, Tom W., et al.
Publicado: (2023)

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
por: Giesen, P. L. A., et al.
Publicado: (2021)

Thrombin Generation in the Glasgow Myocardial Infarction Study
por: Smid, Machiel, et al.
Publicado: (2013)

Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
por: Busch, Matthias H., et al.
Publicado: (2022)

Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
por: D'Alessandro, Elisa, et al.
Publicado: (2021)

The hypercoagulable profile of patients with stent thrombosis
por: Loeffen, R, et al.
Publicado: (2015)

Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events
por: Loeffen, Rinske, et al.
Publicado: (2016)

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
por: de Breet, C. P. D. M., et al.
Publicado: (2021)

Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO
por: Streng, Alexander S., et al.
Publicado: (2020)

Thrombin in complex with dabigatran can still interact with PAR‐1 via exosite‐I and instigate loss of vascular integrity
por: Dólleman, Sophie C., et al.
Publicado: (2022)

Decreased serial scores of severe organ failure assessments are associated with survival in mechanically ventilated patients; the prospective Maastricht Intensive Care COVID cohort
por: Bels, Julia L.M., et al.
Publicado: (2021)

Genetic and Pharmacological Modifications of Thrombin Formation in Apolipoprotein E-deficient Mice Determine Atherosclerosis Severity and Atherothrombosis Onset in a Neutrophil-Dependent Manner
por: Borissoff, Julian I., et al.
Publicado: (2013)

Serial measurements in COVID-19-induced acute respiratory disease to unravel heterogeneity of the disease course: design of the Maastricht Intensive Care COVID cohort (MaastrICCht)
por: Tas, Jeanette, et al.
Publicado: (2020)

Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes
por: Sommeijer, Dirkje W, et al.
Publicado: (2005)

Thrombin generation in cardiovascular disease and mortality – results from the Gutenberg Health Study
por: van Paridon, Pauline C.S., et al.
Publicado: (2019)

Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background
por: van Paridon, Pauline C. S., et al.
Publicado: (2022)

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
por: Kuiper, Gerhardus J. A. J. M., et al.
Publicado: (2016)

Evaluation of the analytical performance of the PC100 platelet counter
por: Nagy, Magdolna, et al.
Publicado: (2021)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Coronary Artery Calcifications Are Associated With More Severe Multiorgan Failure in Patients With Severe Coronavirus Disease 2019 Infection: Longitudinal Results of the Maastricht Intensive Care COVID Cohort
por: Martens, Bibi, et al.
Publicado: (2022)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

The effectivity of the new improved Maastricht brace compared with the Boston brace
por: Hermus, J, et al.
Publicado: (2012)

The Composition and Physical Properties of Clots in COVID-19 Pathology
por: Dauwerse, Sierk, et al.
Publicado: (2022)

Carotid stiffness is associated with retinal microvascular dysfunction—The Maastricht study
por: van der Heide, Frank C. T., et al.
Publicado: (2021)

Association of the Amount and Pattern of Physical Activity With Arterial Stiffness: The Maastricht Study
por: Vandercappellen, Evelien J., et al.
Publicado: (2020)

Diabetes- versus smoking-related thrombo-inflammation in peripheral artery disease
por: Alnima, T., et al.
Publicado: (2023)

Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis
por: Akbulut, Asim Cengiz, et al.
Publicado: (2023)

Rotational Thromboelastometry in High-Risk Patients on Dual Antithrombotic Therapy After Percutaneous Coronary Intervention
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Associations of Dietary Patterns with Incident Depression: The Maastricht Study
por: Gianfredi, Vincenza, et al.
Publicado: (2021)

The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study
por: Nielen, Johannes T. H., et al.
Publicado: (2018)

The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study
por: Gulpen, Anouk J. W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_14c07g2ph6nb8nni6i3jqks9se